REG - CVS Group plc - Total Voting Rights

CVSAnnouncement

Today 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260227:nRSa6122Ua&default-theme=true

RNS Number : 6122U  CVS Group plc  27 February 2026

27 February 2026

 

CVS Group plc

("CVS" or the "Company")

Total Voting Rights

CVS, the UK's listed veterinary group and a leading provider of veterinary
services, confirms that certain employees have exercised options under the CVS
Group 2023 SAYE Plan (2023-2026) and 2024 SAYE Plan (2024/2027) totalling 510
ordinary shares of 0.2 pence each ("Ordinary Shares").

The sum of 510 new Ordinary Shares were issued to satisfy the balance of
Ordinary Shares arising from the SAYE Exercise.  Admission of the 510 new
Ordinary Shares has been satisfied by the Company's block listing admitted to
the London Stock Exchange on 30 December 2021.

The Company has a total issued share capital of 70,156,603 Ordinary Shares,
each carrying one voting right. The Company holds no Ordinary Shares in
treasury and the total number of voting rights is therefore 70,156,603.

This figure may be used by shareholders as the denominator for the
calculations by which they will determine if they are required to notify their
interest, or a change to their interest, in the Company under the FCA's
Disclosure Guidance and Transparency Rules.

Contacts:

CVS
Group plc
        via Camarco

Scott Morrison, General Counsel and Company Secretary

 

Camarco (Financial
PR)

Ginny Pulbrook
 
       +44 (0)7961 315 138

Letaba Rimell

Tilly Butcher

 About CVS Group plc (www.cvsukltd.co.uk (http://www.cvsukltd.co.uk/) )

   CVS Group is a leading provider of veterinary services, operating in the
UK and Australia, listed on

   the Main Market of the London Stock Exchange. CVS is focused on providing
high-quality clinical

   services to its clients and their animals, with outstanding and dedicated
clinical teams and support

   colleagues at the core of its strategy.

   The Group operates over 475 veterinary practices across its two
territories, including specialist

   referral hospitals and dedicated out-of-hours sites. Alongside the core
Veterinary Practices division,

   CVS operates Laboratories (providing diagnostic services to CVS and
third-parties) and an online

   retail business ("Animed Direct").

   The Group employs 9,000 personnel, including 2,500 veterinary surgeons
and 3,300 nurses.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  TVRAKABKCBKDOBB



            Copyright 2019 Regulatory News Service, all rights reserved